"Brain tumors; Hodgkins disease"^^ . "CeeNUSYDTPNSC0079037" . "Lomustine"^^ . "Pharmacologic Substance"^^ . "43065"^^ . "An anticancer drug that belongs to the family of drugs called alkylating agents.NCI-GLOSS" . "N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosoureaSNNCI" . "LucostineFBNCI" . "CCNUABNCI" . "Lomustine"^^ . "1-Nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-SYDTPNSC0079037" . "C0699181"^^ . "LomeblastinFBNCI" . "7BRF0Z81KG"^^ . "WR-139017CNNCI" . "1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosoureaSYDTPNSC0079037" . "79037"^^ . "FDA"^^ . "BelustinFBNCI" . "CeeNUBRNCI" . "LomustinePTNCI" . "N-(2-Chloroethyl)-N'-cyclohexyl-N-nitrosoureaSYDTPNSC0079037" . "43065"^^ . "LOMUSTINEPTFDA7BRF0Z81KG" . "C617"^^ . "RB-1509CNNCI" . "ChloroethylcyclohexylnitrosoureaSYNCI" . "Chloroethylcyclo- hexylnitrosoureaSNNCI" . "BelustineFBNCI" . "13010-47-4"^^ . "PravaFBNCI" . . . "A nitrosourea with antineoplastic activity. Lomustine alkylates and crosslinks DNA, thereby inhibiting DNA and RNA synthesis. This agent also carbamoylates DNA and proteins, resulting in inhibition of DNA and RNA synthesis and disruption of RNA processing. Lomustine is lipophilic and crosses the blood-brain barrier. (NCI04)NCI" . . "CCNUSYDTPNSC0079037" . "BelustineSYDTPNSC0079037" . "CecenuFBNCI" . "Lomustine"^^ . "LomustinumSYNCI" . "AIDS-related non-Hodgkins lymphoma; Brain tumor; Central nervous system lymphoma; Malignant glioma; Medulloblastoma"^^ . "1-(2-chloroethyl)-3-cyclohexyl-1-nitrosoureaSNNCI" . "CitostalFBNCI" . "CecenuSYDTPNSC0079037" . "lomustinePTNCI-GLOSSCDR0000046017" . "LucostinFBNCI" . "ChloroethylcyclohexylnitrosoureaSYDTPNSC0079037" . . "Organic Chemical"^^ . "C9H16ClN3O2"^^ . .